Results 11 to 20 of about 1,119,938 (307)
Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. [PDF]
, 2013 In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to Samuel Ajayi, Ballif, M, Gnokoro, Joachim Charles, Claire Graber (473716), Charlotte Lewden, Sued, O, Cortés Moncada, Claudia, Gabriela Carriquiry, Ballif, Marie, Gnokoro Joachim Charles, Egger, M, Garone Daniela, International epidemiological Databases to Evaluate Aids,, Marie Ballif, Eefje Jong, Matthias Egger (24558), Lewden, C, Kiertiburanakul, Sasisopin, Joachim Charles Gnokoro (473721), Kiertiburanakul, S, Omar Sued (132831), Carriquiry, Gabriela, Carriquiry Gabriela, Wools-Kaloustian Kara, Lewden, Charlotte, Charlotte Lewden (330442), Jean Claude Dusingize (473718), Lameck Diero, Lameck Diero (473722), Kathryn Anastos, Cortes Claudia P., Daniela Garone, International epidemiological Databases to Evaluate AIDS (IeDEA), Ballif Marie, Sterling, T R, Kara Wools-Kaloustian, Fenner Lukas, Nicolas Durier (326615), Durier, N, Nicolas Durier, Timothy R Sterling, Carriquiry, G, Daniela Garone (383442), Barbara Castelnuovo, Lukas Fenner (149822), Sterling, Timothy R, Gabriela Carriquiry (199604), Jong Eefje, Cortes, C P, Anastos, Kathryn, Dusingize, J C, Barbara Castelnuovo (10700), Jong, E, Diero, L, Joachim Charles Gnokoro, Venerandah Nhandu (473717), Ajayi, Samuel, Kiertiburanakul Sasisopin, Garone, D, for the International epidemiological Databases to Evaluate AIDS (IeDEA), Sasisopin Kiertiburanakul (427725), Matthias Egger, Durier, Nicolas, Dusingize, Jean Claude, Nhandu Venerandah, Anastos Kathryn, Kathryn Anastos (119435), Eefje Jong (473720), Durier Nicolas, Castelnuovo Barbara, Sasisopin Kiertiburanakul, Sued Omar, Wools-Kaloustian, Kara, Dusingize Jean Claude, Samuel Ajayi (364894), Gnokoro, J C, Castelnuovo, B, Cortes, Claudia P, Kara Wools-Kaloustian (375804), Fenner, Lukas, Cortes, Claudia P., Egger, Matthias, Egger Matthias, Lewden Charlotte, Claudia P. Cortes (473719), Wools-Kaloustian, K, Jong, Eefje, Venerandah Nhandu, Timothy R. Sterling (148936), Diero, Lameck, Sued, Omar, Ajayi Samuel, Lukas Fenner, Omar Sued, Claire Graber, Marie Ballif (368655), Nhandu, Venerandah, Jean Claude Dusingize, Claudia P Cortes, Sterling, Timothy R., Graber, Claire, Castelnuovo, Barbara, Diero Lameck, Graber, C, Anastos, K, Sterling Timothy R., Graber Claire, Nhandu, V, Ajayi, S, Garone, Daniela, Fenner, L +110 morecore +1 more sourceTuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis [PDF]
, 2013 Summary Tuberculosis (TB) remains a major public health concern in most low-income countries. Hence, rapid and sensitive TB diagnostics play an important role in detecting and preventing the disease. In addition to established diagnostic methods, several Aliya, Bekmurzayeva, Sypabekova, Marzhan, Kanayeva, Damira, Bekmurzayeva, Aliya +3 morecore +2 more sourcesFinal Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
New England Journal of Medicine, 2019 BACKGROUND
Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without ...D. Tait, M. Hatherill, Olivier Van Der Meeren, A. Ginsberg, Elana van Brakel, B. Salaun, T. Scriba, E. J. Akité, H. Ayles, A. Bollaerts, M. Demoitié, A. Diacon, T. Evans, P. Gillard, Elizabeth Hellström, J. Innes, Maria Lempicki, M. Malahleha, N. Martinson, Doris Mesia Vela, M. Muyoyeta, V. Nduba, Thierry G Pascal, M. Tameris, Friedrich Thienemann, R. Wilkinson, F. Roman +26 moresemanticscholar +1 more sourceOfficial American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Clinical Infectious Diseases, 2017 Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]).David Lewinsohn, M. Leonard, P. Lobue, D. Cohn, C. Daley, E. Desmond, J. Keane, Deborah Lewinsohn, A. Loeffler, G. Mazurek, R. O'brien, M. Pai, L. Richeldi, M. Salfinger, T. Shinnick, T. Sterling, D. Warshauer, G. Woods +17 moresemanticscholar +1 more sourceRapid Molecular Detection of Tuberculosis and Rifampin Resistance
New England Journal of Medicine, 2010 Background Global control of tuberculosis is hampered by slow, insensitive diagnostic methods, particularly for the detection of drug-resistant forms and in patients with human immunodeficiency virus infection.C. Boehme, P. Nabeta, D. Hillemann, M. Nicol, S. Shenai, F. Krapp, J. Allen, Rasim Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, Martin Jones, S. M. O’Brien, D. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, M. Perkins +18 moresemanticscholar +1 more sourceTuberculosis [PDF]
European Respiratory Review, 2014 Tuberculosis remains a serious health problem worldwide, particularly affecting the poorest in both high-income and developing countries. It was declared a global emergency by the World Health Organization in 1993. Central nervous system (CNS) tuberculosis is caused by mycobacteria belonging to the Mycobacterium tuberculosis complex, and is acquired ...openaire +5 more sourcesThe Risk of Tuberculosis in Children After Close Exposure: An Individual-Participant Meta-analysis Including 137,647 Children from 46 Cohort Studies
The Lancet, 2020 Background. Tens of millions of children are exposed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates of the risk of developing tuberculosis in exposed children.L. Martinez, Olivia Cords, C. Horsburgh, J. Andrews, C. Acuña-Villaorduña, S. Ahuja, N. Altet, O. Augusto, Davit Baliashvili, S. Basu, M. Becerra, M. Bonnet, W. Boom, M. Borgdorff, F. Boulahbal, A. C. Carvalho, J. Caylà, T. Chakhaia, P. Chan, T. Cohen, J. Croda, S. Datta, H. D. Corral, J. Denholm, R. Dietze, C. Dobler, S. Donkor, U. Egere, J. Ellner, M. Espinal, C. Evans, C. Fang, K. Fielding, G. Fox, L. Garcia, A. García-Basteiro, S. Geis, S. Graham, L. Grandjean, D. Hannoun, M. Hatherill, A. Hauri, A. Hesseling, P. Hill, Li-Min Huang, H. Huerga, R. Hussain, L. Jarlsberg, E. Jones-López, S. Kato, M. Kato-Maeda, B. Kampmann, H. Kirchner, A. Kritski, C. Lange, C. Lee, Li‐Na Lee, Meng-Rui Lee, A. C. Lemos, C. Lienhardt, D. Ling, Qiao Liu, N. Lo, R. Long, E. López-Varela, P. Lu, M. Magee, LaShaunda L. Malone, A. Mandalakas, N. Martinson, R. Mazahir, M. Murray, E. Netto, L. Otero, J. Parsonnet, A. Reingold, H. S. Schaaf, J. Seddon, S. Sharma, Jitendra Singh, Sarman Singh, R. Sloot, G. Sotgiu, Catherine M. Stein, N. Iqbal, R. Triasih, L. Trieu, M. S. Loeff, P. Stuyft, C. Schalkwyk, R. Vashishtha, L. M. Verhagen, J. Villalba, Jann-Yuan Wang, C. Whalen, T. Yoshiyama, H. Zar, J. Zellweger, Limei Zhu +98 moresemanticscholar +1 more sourceThe New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
mBio, 2017 The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance (RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-negative sputum, and false identification of RIF-R occasionally ...S. Chakravorty, A. Simmons, M. Rowneki, Heta Parmar, Yuan Cao, J. Ryan, P. Banada, Srinidhi Deshpande, S. Shenai, A. Gall, J. Glass, Barry Krieswirth, S. Schumacher, P. Nabeta, N. Tukvadze, C. Rodrigues, A. Skrahina, E. Tagliani, D. Cirillo, A. Davidow, C. Denkinger, D. Persing, R. Kwiatkowski, Martin Jones, D. Alland +24 moresemanticscholar +1 more source
